These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7477390)

  • 1. Deaths prompt calls for drug control review.
    Barker S
    Nature; 1995 Nov; 378(6556):431. PubMed ID: 7477390
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe mefenamic acid poisoning. A case report.
    Shipton EA; Müller FO
    S Afr Med J; 1985 May; 67(20):823-4. PubMed ID: 3992416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of intravenous and oral mefenamic acid poisoning.
    McKillop G; Canning GP
    Scott Med J; 1987 Jun; 32(3):81-2. PubMed ID: 3629224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tysabri withdrawal calls entire class into question.
    Singer E
    Nat Med; 2005 Apr; 11(4):359. PubMed ID: 15812500
    [No Abstract]   [Full Text] [Related]  

  • 5. Mefenamic acid poisoning and epilepsy.
    Robson RH; Balali M; Critchley J; Proudfoot AT; Prescott L
    Br Med J; 1979 Dec; 2(6202):1438. PubMed ID: 519499
    [No Abstract]   [Full Text] [Related]  

  • 6. Mefenamic acid poisoning and epilepsy.
    Young RJ
    Br Med J; 1979 Sep; 2(6191):672. PubMed ID: 497787
    [No Abstract]   [Full Text] [Related]  

  • 7. Coma in mefenamic acid poisoning.
    Gössinger H; Hruby K; Haubenstock A; Jung M; Zwerina N
    Lancet; 1982 Aug; 2(8294):384. PubMed ID: 6124781
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of paracetamol pack size restrictions on poisoning from paracetamol in England and Wales: an observational study.
    Morgan O; Griffiths C; Majeed A
    J Public Health (Oxf); 2005 Mar; 27(1):19-24. PubMed ID: 15637104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The national drug control agency approves of a humbug drug].
    Jacobsen CD
    Tidsskr Nor Laegeforen; 1996 Apr; 116(11):1384. PubMed ID: 8658424
    [No Abstract]   [Full Text] [Related]  

  • 10. Opioid poisoning deaths in New Zealand (2001-2002).
    Reith D; Fountain J; Tilyard M
    N Z Med J; 2005 Feb; 118(1209):U1293. PubMed ID: 15711626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Two years with EMEA: towards a unified drug registration within the EEC].
    Lennholm B
    Lakartidningen; 1997 Jan; 94(1-2):8-12. PubMed ID: 9053613
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA "reform"?
    Miller HI
    Science; 1998 Jan; 279(5348):158-9. PubMed ID: 9446215
    [No Abstract]   [Full Text] [Related]  

  • 13. New drug approval times and clinical evidence in Japan.
    Ono S; Yoshioka C; Asaka O; Tamura K; Shibata T; Saito K
    Contemp Clin Trials; 2005 Dec; 26(6):660-72. PubMed ID: 16122988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contact and dialogue between drug companies and the global regulatory authorities throughout research and development phase].
    Kock M; Thomsen MK
    Ugeskr Laeger; 2003 Apr; 165(16):1649-52. PubMed ID: 12756820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Status of drugs].
    Gindre I; Woronoff-Lemsi MC
    Soins; 1998 Nov; (630):57-8. PubMed ID: 10095734
    [No Abstract]   [Full Text] [Related]  

  • 16. [Paracetamol poisonings in Norway 1990-2001].
    Bøe GH; Haga C; Andrew E; Berg KJ
    Tidsskr Nor Laegeforen; 2004 Jun; 124(12):1624-8. PubMed ID: 15229706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The Medical Product Agency sharpens its control. What is the consequence of bad trials?].
    Naeser SW; Nordlund S
    Lakartidningen; 1993 Dec; 90(51-52):4651-2. PubMed ID: 8264311
    [No Abstract]   [Full Text] [Related]  

  • 18. [Discouraging about drug therapy?].
    Reseland S
    Tidsskr Nor Laegeforen; 2003 Jun; 123(13-14):1910-1. PubMed ID: 12830286
    [No Abstract]   [Full Text] [Related]  

  • 19. Remarks at the Food and Drug Law Institute's 48th Annual Conference.
    Niedelman SM
    Food Drug Law J; 2005; 60(2):117-26. PubMed ID: 16097089
    [No Abstract]   [Full Text] [Related]  

  • 20. Walking the drug regulatory tightrope.
    Dove A
    Nat Biotechnol; 2003 May; 21(5):495-8. PubMed ID: 12721571
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.